These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38326978)
1. Randomized double-blind placebo-controlled cosmetic trial of a topical first-in-class Neutraligand targeting the chemokine TARC/CCL17 in mild-to-moderate atopic dermatitis. Frossard N; Coïc A; Saguet T; Coïc A; Himbert F; Do QT; Galzi JL; Suehs C; Guillaumet G; Bonnet P; Bernard P Int J Cosmet Sci; 2024 Jun; 46(3):468-477. PubMed ID: 38326978 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial. Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study. Wu YJ; Wu WF; Hung CW; Ku MS; Liao PF; Sun HL; Lu KH; Sheu JN; Lue KH J Microbiol Immunol Infect; 2017 Oct; 50(5):684-692. PubMed ID: 26733351 [TBL] [Abstract][Full Text] [Related]
4. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719 [TBL] [Abstract][Full Text] [Related]
5. A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Oral Administration of a Heat-Treated Lactobacillus paracasei Supplement in Infants with Atopic Dermatitis Receiving Topical Corticosteroid Therapy. Yan DC; Hung CH; Sy LB; Lue KH; Shih IH; Yang CY; Chen LC; Sun HL; Lee MS; Chambard J; Tanguy J; Hughes-Formella B; Nutten S; Blanchard C Skin Pharmacol Physiol; 2019; 32(4):201-211. PubMed ID: 31117100 [TBL] [Abstract][Full Text] [Related]
6. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study. Fukaya M; Kimata H J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568 [TBL] [Abstract][Full Text] [Related]
7. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial. Chan S; Cornelius V; Cro S; Harper JI; Lack G JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962 [TBL] [Abstract][Full Text] [Related]
8. Topical treatment of atopic dermatitis with St. John's wort cream--a randomized, placebo controlled, double blind half-side comparison. Schempp CM; Windeck T; Hezel S; Simon JC Phytomedicine; 2003; 10 Suppl 4():31-7. PubMed ID: 12807340 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of a probiotic supplement in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled clinical trial. Michelotti A; Cestone E; De Ponti I; Giardina S; Pisati M; Spartà E; Tursi F Eur J Dermatol; 2021 Apr; 31(2):225-232. PubMed ID: 33871363 [TBL] [Abstract][Full Text] [Related]
10. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603 [TBL] [Abstract][Full Text] [Related]
11. [Topical treatment of atopic dermatitis with Hypericum cream. A randomised, placebo-controlled, double-blind half-side comparison study]. Schempp CM; Hezel S; Simon JC Hautarzt; 2003 Mar; 54(3):248-53. PubMed ID: 12634994 [TBL] [Abstract][Full Text] [Related]
12. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial. Jin SY; Lim WS; Sung NH; Cheong KA; Lee AY Dermatol Ther; 2015; 28(1):44-51. PubMed ID: 25113885 [TBL] [Abstract][Full Text] [Related]
13. A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis. Goh SW; Jamil A; Safian N; Md Nor N; Muhammad N; Saharudin NL An Bras Dermatol; 2020; 95(3):320-325. PubMed ID: 32291095 [TBL] [Abstract][Full Text] [Related]
15. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957 [TBL] [Abstract][Full Text] [Related]
16. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis. Gu CY; Gu L; Dou X Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Meysami M; Hashempur MH; Kamalinejad M; Emtiazy M Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1673-1678. PubMed ID: 33100212 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]